23 Jul, 2026
According to Straits Research, the global neuropathic pain market size was valued at $7.92 billion in 2025 and is expected to grow from $8.61 billion in 2026 to $16.81 billion by 2034, registering a CAGR of 8.73% during the forecast period (2026–2034).
Neuropathic pain is a persistent pain condition caused by nerve damage or dysfunction in the nervous system. It is distinct from nociceptive pain, which results from tissue injury or inflammation. Neuropathic pain arises from various conditions such as diabetes, multiple sclerosis, spinal cord injuries, infections, chemotherapy-induced nerve damage, and postherpetic neuralgia. It often manifests as burning, stabbing, or electric shock-like sensations, significantly affecting the patient’s quality of life.
The global neuropathic pain market is expanding rapidly due to the rising prevalence of diabetic neuropathy, post-herpetic neuralgia, multiple sclerosis, and chemotherapy-induced neuropathy. Since neuropathic pain is chronic and requires ongoing management, drug therapies like anticonvulsants, antidepressants, and NSAIDs are widely used alongside non-drug treatments such as neurostimulation, TENS, and acupuncture. Advances in neuromodulation techniques and AI-based pain monitoring also foster innovation in neuropathic pain treatment solutions.
Increasing prevalence of diabetic neuropathy drives the market growth
Diabetic neuropathy is a common diabetes complication caused by nerve damage due to prolonged high blood sugar levels. Its growing incidence underscores the need for improved diabetes treatments that focus on managing neuropathic pain.
Additionally, the rising prevalence of diabetic complications highlights the demand for more effective treatment options for neuropathic pain in diabetic patients. In addition, advancements in neuromodulation therapies have driven substantial growth in the neuropathic pain market. Continuous research on neurostimulation therapies and technological innovation in devices have positioned neuromodulation as a promising treatment for neuropathic pain management.
Rising demand for digital health solutions creates tremendous opportunities
The increasing adoption of digital health technologies offers a valuable opportunity for improving neuropathic pain care. Mobile health applications, wearable devices, telemedicine, and remote patient monitoring enable patients to track symptoms, receive instant feedback, and access specialized care remotely. These innovations improve patient engagement, making personalized pain management more convenient and accessible.
The growing demand for digital health solutions presents a promising market opportunity for neuropathic pain management.
North America leads the global neuropathic pain market due to the high prevalence of diseases such as diabetes, multiple sclerosis, and cancer. The region’s advanced healthcare infrastructure, large patient population, and access to modern drug— and non-drug-based therapies contribute to this dominance. Furthermore, ongoing R&D efforts, the development of novel treatments, and supportive regulatory policies in the U.S. continue to propel the neuropathic pain market in North America.
sales@straitsresearch.com